Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Zimmer Biomet Holdings ( (ZBH) ) has provided an announcement.
On January 28, 2025, Zimmer Biomet Holdings announced a definitive agreement to acquire Paragon 28, a leading company in the foot and ankle orthopedic segment, for approximately $1.2 billion. The deal is expected to bolster Zimmer Biomet’s offerings in the high-growth foot and ankle segment, with projections to enhance revenue and earnings within 24 months of closing. The merger will leverage Paragon’s innovative product portfolio and Zimmer Biomet’s global reach to address unmet patient needs, with anticipated benefits including accelerated revenue growth and expanded market penetration.
More about Zimmer Biomet Holdings
Zimmer Biomet Holdings, Inc. is a global leader in medical technology, specializing in products that enhance mobility and health through innovative technology. The company offers a comprehensive portfolio of digital and robotic solutions, catering to various medical needs in over 100 countries. Paragon 28, based in Englewood, Colorado, focuses exclusively on the foot and ankle orthopedic segment, providing advanced orthopedic solutions for a wide range of foot and ankle conditions.
YTD Price Performance: 7.08%
Average Trading Volume: 1,639,399
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $22.27B
See more data about ZBH stock on TipRanks’ Stock Analysis page.
